Effectiveness and safety of extended treatment with direct oral anticoagulants for venous thromboembolism in Japan: A retrospective cohort study using claims data
Purpose: We aimed to evaluate the risk of recurrent venous thromboembolism (VTE) among patients receiving direct oral anticoagulant (DOAC) therapy (extended and non-extended) using claims data. Methods: Patients treated with DOACs at the first VTE event were identified using Japanese claims data; Co...
Main Authors: | Hiroyuki Hashimoto, Shinobu Imai, Anna Kiyomi, Munetoshi Sugiura |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-08-01
|
Series: | Thrombosis Update |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666572722000177 |
Similar Items
-
Clinical and Safety Outcomes Associated with Extended Treatment of Venous Thromboembolism: A Network Meta-Analysis
by: Zhiqiang Liu, et al.
Published: (2022-11-01) -
Primary Care Clinicians’ Prescribing Patterns of Reduced-Dose Direct Oral Anticoagulants for Extended-Phase Venous Thromboembolism Treatment
by: Danielle Groat, et al.
Published: (2023-12-01) -
Optimal duration of anticoagulant therapy in patients with venous thromboembolism
by: Gualtiero Palareti
Published: (2018-09-01) -
Safe and effective treatment of venous Thromboembolism associated with Cancer: focus on direct Oral Anticoagulants in Asian patients
by: Lai Heng Lee, et al.
Published: (2022-10-01) -
Cost-effectiveness of new oral anticoagulants in the treatment and secondary prevention of venous thromboembolism
by: A. V. Rudakova
Published: (2015-11-01)